Table 1. Open in new tab Differences on...

Characteristic¹

Without DSH, N = 1008²

With DSH, N = 187²

P-value³

q-value⁴

Age (Baseline)

21.4 (3.4)

20.5 (3.2)

.001

0.002

Sex

>0.9

Male

524 (52%)

96 (51%)

Female

484 (48%)

91 (49%)

Treatment

.11

0.12

Standard care

485 (48%)

102 (55%)

Early intervention

523 (52%)

85 (45%)

Education years

10.84 (2.44)

9.96 (2.15)

<.001

<0.001

Age of onset

20.7 (3.5)

19.9 (3.3)

.006

0.008

DUP (Days)

259 (425)

219 (329)

>.9

>0.9

NSSI in DUP

35 (3.5%)

18 (9.6%)

<.001

<0.001

SA in DUP

62 (6.2%)

30 (16%)

<.001

<0.001

Illicit substance use (Lifetime)

71 (7.0%)

28 (15%)

<.001

<0.001

Substance abuse (Baseline)

13 (1.3%)

4 (2.1%)

0.4

Current smoker

249 (25%)

62 (34%)

.016

0.022

Diagnosis

.002

0.003

Schizophrenia

775 (77%)

163 (87%)

Other Schizophrenia spectrum

233 (23%)

24 (13%)

Hospitalization at onset

692 (69%)

157 (84%)

<.001

<0.001

Days of 1st hospitalization admission

59 (77)

72 (91)

.032

0.041

Pos. Symptom (36 m Mean)

1.68 (0.80)

1.80 (0.68)

<.001

<0.001

Neg. Symptom (36 m Mean)

1.52 (0.64)

1.58 (0.49)

<.001

<0.001

Dep. Symptom (36 m Mean)

1.24 (0.39)

1.36 (0.35)

<.001

<0.001

SOFAS (36 m Mean)

59 (11)

54 (8)

<0.001

<0.001

Medication adherence (36 m Mean)

1.19 (0.33)

1.17 (0.23)

0.037

0.044

Pos. Symptom (36 m MSSD)

0.56 (0.52)

0.86 (0.61)

<0.001

<0.001

Neg. Symptom (36 m MSSD)

0.35 (0.36)

0.52 (0.39)

<0.001

<0.001

Dep. Symptom (36 m MSSD)

0.34 (0.53)

0.62 (0.57)

<0.001

<0.001

SOFAS (36 m MSSD)

39 (39)

54 (44)

<0.001

<0.001

Medication adherence (36 m MSSD)

0.22 (0.38)

0.27 (0.39)

<0.001

0.001

Table 1.

Open in new tab

Differences on Demographics, Premorbid Information and Clinical Variables between Patients with Deliberate Self-harm and Those Without

Characteristic¹	Without DSH, N = 1008²	With DSH, N = 187²	P-value³	q-value⁴
Age (Baseline)	21.4 (3.4)	20.5 (3.2)	.001	0.002
Sex			.9	>0.9
Male	524 (52%)	96 (51%)
Female	484 (48%)	91 (49%)
Treatment			.11	0.12
Standard care	485 (48%)	102 (55%)
Early intervention	523 (52%)	85 (45%)
Education years	10.84 (2.44)	9.96 (2.15)	<.001	<0.001
Age of onset	20.7 (3.5)	19.9 (3.3)	.006	0.008
DUP (Days)	259 (425)	219 (329)	>.9	>0.9
NSSI in DUP	35 (3.5%)	18 (9.6%)	<.001	<0.001
SA in DUP	62 (6.2%)	30 (16%)	<.001	<0.001
Illicit substance use (Lifetime)	71 (7.0%)	28 (15%)	<.001	<0.001
Substance abuse (Baseline)	13 (1.3%)	4 (2.1%)	.3	0.4
Current smoker	249 (25%)	62 (34%)	.016	0.022
Diagnosis			.002	0.003
Schizophrenia	775 (77%)	163 (87%)
Other Schizophrenia spectrum	233 (23%)	24 (13%)
Hospitalization at onset	692 (69%)	157 (84%)	<.001	<0.001
Days of 1st hospitalization admission	59 (77)	72 (91)	.032	0.041
Pos. Symptom (36 m Mean)	1.68 (0.80)	1.80 (0.68)	<.001	<0.001
Neg. Symptom (36 m Mean)	1.52 (0.64)	1.58 (0.49)	<.001	<0.001
Dep. Symptom (36 m Mean)	1.24 (0.39)	1.36 (0.35)	<.001	<0.001
SOFAS (36 m Mean)	59 (11)	54 (8)	<0.001	<0.001
Medication adherence (36 m Mean)	1.19 (0.33)	1.17 (0.23)	0.037	0.044
Pos. Symptom (36 m MSSD)	0.56 (0.52)	0.86 (0.61)	<0.001	<0.001
Neg. Symptom (36 m MSSD)	0.35 (0.36)	0.52 (0.39)	<0.001	<0.001
Dep. Symptom (36 m MSSD)	0.34 (0.53)	0.62 (0.57)	<0.001	<0.001
SOFAS (36 m MSSD)	39 (39)	54 (44)	<0.001	<0.001
Medication adherence (36 m MSSD)	0.22 (0.38)	0.27 (0.39)	<0.001	0.001

Characteristic¹	Without DSH, N = 1008²	With DSH, N = 187²	P-value³	q-value⁴
Age (Baseline)	21.4 (3.4)	20.5 (3.2)	.001	0.002
Sex			.9	>0.9
Male	524 (52%)	96 (51%)
Female	484 (48%)	91 (49%)
Treatment			.11	0.12
Standard care	485 (48%)	102 (55%)
Early intervention	523 (52%)	85 (45%)
Education years	10.84 (2.44)	9.96 (2.15)	<.001	<0.001
Age of onset	20.7 (3.5)	19.9 (3.3)	.006	0.008
DUP (Days)	259 (425)	219 (329)	>.9	>0.9
NSSI in DUP	35 (3.5%)	18 (9.6%)	<.001	<0.001
SA in DUP	62 (6.2%)	30 (16%)	<.001	<0.001
Illicit substance use (Lifetime)	71 (7.0%)	28 (15%)	<.001	<0.001
Substance abuse (Baseline)	13 (1.3%)	4 (2.1%)	.3	0.4
Current smoker	249 (25%)	62 (34%)	.016	0.022
Diagnosis			.002	0.003
Schizophrenia	775 (77%)	163 (87%)
Other Schizophrenia spectrum	233 (23%)	24 (13%)
Hospitalization at onset	692 (69%)	157 (84%)	<.001	<0.001
Days of 1st hospitalization admission	59 (77)	72 (91)	.032	0.041
Pos. Symptom (36 m Mean)	1.68 (0.80)	1.80 (0.68)	<.001	<0.001
Neg. Symptom (36 m Mean)	1.52 (0.64)	1.58 (0.49)	<.001	<0.001
Dep. Symptom (36 m Mean)	1.24 (0.39)	1.36 (0.35)	<.001	<0.001
SOFAS (36 m Mean)	59 (11)	54 (8)	<0.001	<0.001
Medication adherence (36 m Mean)	1.19 (0.33)	1.17 (0.23)	0.037	0.044
Pos. Symptom (36 m MSSD)	0.56 (0.52)	0.86 (0.61)	<0.001	<0.001
Neg. Symptom (36 m MSSD)	0.35 (0.36)	0.52 (0.39)	<0.001	<0.001
Dep. Symptom (36 m MSSD)	0.34 (0.53)	0.62 (0.57)	<0.001	<0.001
SOFAS (36 m MSSD)	39 (39)	54 (44)	<0.001	<0.001
Medication adherence (36 m MSSD)	0.22 (0.38)	0.27 (0.39)	<0.001	0.001

Note:

¹DUP, Duration of Untreated Psychosis; NSSI, Non-Suicidal Self-Injury; SA, Suicidal Attempts; Pos, Positive; Neg, Negative; Dep, Depressive; SOFAS, Social and Occupational Functioning Assessment Scale; MSSD, Mean of the Squared Successive Differences.

²Mean (SD); n (%).

³Wilcoxon rank sum test; Pearson’s Chi-squared test; Fisher’s exact test.

⁴False discovery rate correction for multiple testing.

This Feature Is Available To Subscribers Only